• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of the role of adipose-derived stem cells in renal cell carcinoma and development of new therapeutic strategies

Research Project

Project/Area Number 20K09553
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 56030:Urology-related
Research InstitutionAkita University

Principal Investigator

Numakura Kazuyuki  秋田大学, 医学部附属病院, 病院准教授 (90566415)

Co-Investigator(Kenkyū-buntansha) 明石 英雄  秋田大学, 医学系研究科, 助教 (10431785)
小林 瑞貴  秋田大学, 医学部附属病院, 助教 (20838627)
武藤 弓奈  秋田大学, 医学部附属病院, 医員 (60837706)
松峯 元  東京女子医科大学, 医学部, 准教授 (80598144)
Project Period (FY) 2020-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2022: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2021: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords脂肪由来幹細胞 / 腎細胞癌 / βカテニン / 浸潤 / mesenchymal stem cells / renal cell carcinoma / β-catenin / invasion / migration / PI-3K / 腫瘍微小環境 / drug repositioning
Outline of Research at the Start

本研究では新たなアプローチとして腎周囲脂肪に存在する脂肪由来幹細胞(ADSC)に着目した。ADSCは腫瘍の微小環境を構成する間葉細胞を供給し、腫瘍の形成や進展に関わるが、RCCにおける役割はほとんど知られていない。一方、幹細胞に対するいくつかの薬剤は、すでに他疾患で治療薬として使用されており、もし、ADSCが標的となるのであれば、新規薬剤を開発せずに治療が可能になる(drug repositioning)。すなわち、本研究では、RCCにおけるADSCの役割を明らかにし、早期に臨床応用が可能な治療法の開発を目指す。

Outline of Final Research Achievements

A-MSCs exhibited multipotency, capable of differentiating into adipocytes, chondroblasts, and osteoblasts. R-MSCs showed enhanced mRNA expression of Hes1, Hey1, and Twist, along with increased β-catenin protein levels and decreased phospho-Akt (Ser473) and phospho-p38 MAPK compared to D-MSCs, indicating reduced stem cell potential via molecular pathways. This was further corroborated by aldehyde dehydrogenase enzymatic activity (ALDH) assays, revealing fewer ALDH+ cells in R-MSCs than in D-MSCs. Co-culturing with RCC cell lines demonstrated increased migration with R-MSCs compared to D-MSCs. Pathway analysis revealed elevated CD44 mRNA expression in RCC cell lines co-cultured with R-MSCs. IHC staining of β-catenin in perirenal stromal tissue from RCC surgical specimens revealed a higher positive score correlating with tumor aggressiveness.

Academic Significance and Societal Importance of the Research Achievements

β-カテニンを標的とすることで、従来の治療に耐性を示す腎細胞癌の新規治療となる可能性が示された。

Report

(5 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • 2020 Research-status Report
  • Research Products

    (21 results)

All 2024 2023 2022 2021 2020

All Journal Article (14 results) (of which Peer Reviewed: 14 results,  Open Access: 10 results) Presentation (7 results) (of which Int'l Joint Research: 5 results)

  • [Journal Article] Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma2023

    • Author(s)
      Numakura Kazuyuki、Sekine Yuya、Hatakeyama Shingo、Muto Yumina、Sobu Ryuta、Kobayashi Mizuki、Sasagawa Hajime、Kashima Soki、Yamamto Ryohei、Nara Taketoshi、Akashi Hideo、Tabata Ryuji、Sato Satoshi、Saito Mitsuru、Narita Shintaro、Ohyama Chikara、Habuchi Tomonori
    • Journal Title

      Cancer Medicine

      Volume: 12 Issue: 16 Pages: 16837-16845

    • DOI

      10.1002/cam4.6306

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG2023

    • Author(s)
      Numakura Kazuyuki、Miyake Makito、Kobayashi Mizuki、et al.
    • Journal Title

      Cancers

      Volume: 15 Issue: 7 Pages: 2002-2002

    • DOI

      10.3390/cancers15072002

    • Related Report
      2023 Annual Research Report 2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer2023

    • Author(s)
      Numakura Kazuyuki、Kobayashi Mizuki、Muto Yumina、Sato Hiromi、Sekine Yuya、Sobu Ryuta、Aoyama Yu、Takahashi Yoshiko、Okada Syuhei、Sasagawa Hajime、Narita Shintaro、Kumagai Satoshi、Wada Yuki、Mori Naoko、Habuchi Tomonori
    • Journal Title

      Current Oncology

      Volume: 30 Issue: 9 Pages: 8092-8110

    • DOI

      10.3390/curroncol30090587

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Androgen deprivation therapy caused a drastic proliferation of B-cell lymphoma with IgG4-related disease in patients with prostate cancer: a case report2023

    • Author(s)
      Sasagawa Hajime、Numakura Kazuyuki、Mori Mizuki、Kobayashi Mizuki、Kashima Soki、Yamamoto Ryohei、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Nanjo Hiroshi、Habuchi Tomonori
    • Journal Title

      Journal of Cancer Research and Clinical Oncology

      Volume: 149 Issue: 16 Pages: 15091-15094

    • DOI

      10.1007/s00432-023-05292-y

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75?years old2023

    • Author(s)
      Kobayashi Mizuki、Numakura Kazuyuki、Hatakeyama Shingo、Ishida Toshiya、Koizumi Atsushi、Tadachi Kazuki、Igarashi Ryoma、Takayama Koichiro、Muto Yumina、Sekine Yuya、Sobu Ryuta、Sasagawa Hajime、Akashi Hideo、Kashima Soki、Yamamoto Ryohei、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Ohyama Chikara、Habuchi Tomonori
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 28 Issue: 11 Pages: 1530-1537

    • DOI

      10.1007/s10147-023-02394-y

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical impact of early response to first‐line <scp>VEGFR‐TKI</scp> in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study2022

    • Author(s)
      Sobu Ryuta、Numakura Kazuyuki、Naito Sei、Hatakeyama Shingo、Kato Renpei、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Syuya、Kawamura Sadafumi、Arai Yoichi、Ito Akihiro、Nishiyama Hiroyuki、Kojima Yoshiyuki、Obara Wataru、Ohyama Chikara、Tsuchiya Norihiko、Habuchi Tomonori
    • Journal Title

      Cancer Medicine

      Volume: 12 Issue: 4 Pages: 4100-4109

    • DOI

      10.1002/cam4.5268

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism2022

    • Author(s)
      Kobayashi Mizuki、Numakura Kazuyuki、Hatakeyama Shingo、Muto Yumina、Sekine Yuya、Sasagawa Hajime、Kashima Soki、Yamamoto Ryohei、Koizumi Atsushi、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Ohyama Chikara、Habuchi Tomonori
    • Journal Title

      Genes

      Volume: 13 Issue: 7 Pages: 1204-1204

    • DOI

      10.3390/genes13071204

    • Related Report
      2022 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study2022

    • Author(s)
      Numakura Kazuyuki、Kobayashi Mizuki、Ishida Toshiya、et al.
    • Journal Title

      European Urology Focus

      Volume: 8 Issue: 6 Pages: 1666-1672

    • DOI

      10.1016/j.euf.2022.06.002

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Factors influencing warm ischemia time in robot-assisted partial nephrectomy change depending on the surgeon’s experience2022

    • Author(s)
      Numakura Kazuyuki、Kobayashi Mizuki、Koizumi Atsushi、Kashima Soki、Yamamoto Ryohei、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Inoue Takamitsu、Habuchi Tomonori
    • Journal Title

      World Journal of Surgical Oncology

      Volume: 20 Issue: 1 Pages: 202-202

    • DOI

      10.1186/s12957-022-02669-0

    • Related Report
      2022 Research-status Report
    • Peer Reviewed
  • [Journal Article] Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era2021

    • Author(s)
      Numakura Kazuyuki、Muto Yumin、Naito Sei、Hatakeyama Shingo、Kato Renpei、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Syuya、Kawamura Sadafumi、Arai Yoichi、Ito Akihiro、Nishiyama Hiroyuki、Kojima Yoshiyuki、Obara Wataru、Ohyama Chikara、Tsuchiya Norihiko、Habuchi Tomonori
    • Journal Title

      Cancer Medicine

      Volume: 10 Issue: 17 Pages: 5839-5846

    • DOI

      10.1002/cam4.4130

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology2020

    • Author(s)
      Numakura Kazuyuki、Kobayashi Mizuki、Muto Yumina、Sekine Yuya、Takahashi Makoto、Kashima Soki、Yamamoto Ryohei、Koizumi Atsushi、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Nanjyo Hiroshi、Habuchi Tomonori
    • Journal Title

      Scientific Reports

      Volume: 10 Issue: 1 Pages: 20089-20089

    • DOI

      10.1038/s41598-020-77135-6

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Robotic-assisted laparoscopic partial nephrectomy for renal cell carcinoma in horseshoe kidney: a hybrid technique with conventional laparoscopic surgery2020

    • Author(s)
      Numakura Kazuyuki、Muto Yumina、Yamamoto Ryohei、Koizumi Atsushi、Nara Taketoshi、Kanda Sohei、Saito Mitsuru、Narita Shintaro、Inoue Takamitsu、Habuchi Tomonori
    • Journal Title

      International Cancer Conference Journal

      Volume: 9 Issue: 4 Pages: 199-202

    • DOI

      10.1007/s13691-020-00420-8

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75?years old from multiple Japanese institutes2020

    • Author(s)
      Numakura Kazuyuki、Kobayashi Mizuki、Hatakeyama Shingo、Naito Sei、Horikawa Yohei、Tanaka Toshikazu、Kamada Sachiko、Muto Yumina、Yamamoto Ryohei、Koizumi Atsushi、Nara Taketoshi、Kanda Sohei、Saito Mitsuru、Narita Shintaro、Inoue Takamitsu、Shimoda Naotake、Tsuchiya Norihiko、Ohyama Chikara、Habuchi Tomonori
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 25 Issue: 8 Pages: 1543-1550

    • DOI

      10.1007/s10147-020-01693-y

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Robot-assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction with duplex system.2020

    • Author(s)
      Numakura K, Muto Y, Saito M, Narita S, Inoue T, Habuchi T.
    • Journal Title

      Urol Case Rep

      Volume: 30 Pages: 101138-101138

    • DOI

      10.1016/j.eucr.2020.101138

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Activation of canonical pathway in mesenchymal stem cells&#160;induces tumor aggressiveness in renal cell carcinoma2024

    • Author(s)
      武藤弓奈
    • Organizer
      日本泌尿器科学会総会
    • Related Report
      2023 Annual Research Report
  • [Presentation] 腫瘍周囲の脂肪由来間葉系幹細胞は腎癌細胞の浸潤を促進する2023

    • Author(s)
      武藤弓奈
    • Organizer
      分子細胞研究会
    • Related Report
      2023 Annual Research Report
  • [Presentation] Cancer-associated adipose-derived mesenchymal stem cells promote migration and invasion in kidney cancer2022

    • Author(s)
      Yumina Muto
    • Organizer
      The American Urological Association Meeting
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research
  • [Presentation] Cancer-associated adipose-derived mesenchymal stem cells promote migration and invasion in kidney cancer2022

    • Author(s)
      Yumina Muto
    • Organizer
      The European Association of Urology Meeting
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research
  • [Presentation] Cancer-associated adipose-derived mesenchymal stem cells promote migration and invasion in kidney cancer2022

    • Author(s)
      Muto Yumina
    • Organizer
      Annual Meeting of the American Urological Association
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research
  • [Presentation] Cancer-associated adipose-derived mesenchymal stem cells promote migration and invasion in kidney cancer2022

    • Author(s)
      Muto Yumina
    • Organizer
      Annual Meeting the European Association of Urology Annual Meeting
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research
  • [Presentation] Adipose-derived mesenchymal stem cells promoted invasion of kidney cancer cell line in vitro study2021

    • Author(s)
      Muto Yumina
    • Organizer
      Annual Meeting of the Japanese Cancer Association
    • Related Report
      2021 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2020-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi